Lucence and Yemaachi Launch the AMBER Study to Detect and Characterize Genomic Alterations in Breast Cancer in Women in Africa and Expand Liquid Biopsy Access. PALO ALTO, Calif. & ACCRA, Ghana, CA-LUCENCE
Media Jack Challis Lucence media@lucence.com Yemaachi info@yemaachi.com
